Navigation Links
AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma
Date:3/11/2010

ong-acting beta2-adrenergic agonist (salmeterol) or placebo added to usual asthma therapy showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol may apply to formoterol (a long-acting beta2-adrenergic agonist), one of the active ingredients in SYMBICORT (see WARNINGS in full Prescribing Information).

SYMBICORT is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms.

Particular care is needed for patients who are transferred from systemically active corticosteroids to inhaled corticosteroids. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids.

Patients who are receiving SYMBICORT should not use additional formoterol or other long-acting inhaled beta2-agonists for any reason.

Caution should be exercised when considering the coadministration of SYMBICORT with long-term ketoconazole and other known potent CYP3A4 inhibitors.


'/>"/>
SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
2. AstraZeneca Offers Online Enrollment and Additional Improvements to Patient Assistance Program
3. Novexel to be Acquired by AstraZeneca
4. AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays
5. U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
6. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
7. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
8. Jubilant Enters Research Collaboration With AstraZeneca
9. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
10. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
11. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Mass. , Aug. 27, 2015  A ... the KSSTA Knee Journal, compared the Arthrosurface HemiCAP® ... Arthroplasty design, versus an "onlay" design implant for ... similar improvements in function and pain scores, none ... progression of osteoarthritis (OA). However, 53% of the ...
(Date:8/27/2015)... , Aug. 27, 2015 Biosimilars ... (BPC) applauds the U.S. Food and Drug Administration ... distinguishable name in its draft guidance issued today. ... biological products proposes distinguishable names, calling for biological ... an FDA-designated suffix. This proposal reflects the agency,s ...
(Date:8/27/2015)... 2015 According to a new market research ... Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, ... by MarketsandMarkets, the Medical Lifting Sling Market is poised to reach ... at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
(Date:8/28/2015)... ... August 28, 2015 , ... Altima ... and diagramming network and data center assets and audio-video devices, recently released Visio ... Nexus 5000 Series, HP ProLiant Gen9, EMC VNX Series , Super Micro Computer ...
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... patient loyalty at a low cost. Personalized with practice contact information and logos, ... patients. Dental offices can also incorporate Calendars into seasonal mailings, thank you and ...
(Date:8/28/2015)... ... , ... Mendon, IL, home of the Adams County Fairgrounds, was treated once ... good cause. In its second year, the “Music With A Mission” benefit concert was ... “Mission” of “Music With A Mission” is to raise money to help fund music ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... which is dedicated to distributing health information technology innovation to transform quality and ... Results of the survey will be de-identified and aggregated before being publicly shared ...
Breaking Medicine News(10 mins):Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:MyGenetx Board Member Receives Veterans Award 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2
... When a child is born the lives ... centered around the safety,happiness and success of this ... and,days are spent thinking about soccer practice carpools, ... when that future tragically,disappears? Experts from Brookhaven ...
... require intensive care, one expert says , , FRIDAY, Jan. 16 ... women struggling with postpartum depression can be treated effectively by ... two studies find. , Both reports, published in the Jan. ... talk therapy and caring communication can help new mothers deal ...
... Thousands of Catholics will gather in the Basilica of ... an end to abortion at the National Prayer Vigil for ... eve of the 36th anniversary of Roe v. Wade ... - many of them youth from schools around the nation ...
... BALTIMORE, Jan. 16 Lupin Pharmaceuticals, Inc. (LPI) ... for the Company,s Abbreviated New Drug Application (ANDA) ... from the U.S. Food and Drug Administration (USFDA). ... Levetiracetam tablets are the AB-rated generic equivalent of ...
... - During a teleconference on Monday, three ... dual action iron supplement pill with virtually no gastrointestinal ... nutritional benefits from iron to be available without a ... FISSN, CSCS; Curt Behrens, president of P2B Inc. ...
... announces the availability of a specialized search ... health care professionals. The site allows dentistry ... research, equipment specifications, continuing education, and dental ... can find what they are looking for ...
Cached Medicine News:Health News:Overwhelming Grief From Loss of Child Can Cause Substance Abuse in Women 2Health News:Overwhelming Grief From Loss of Child Can Cause Substance Abuse in Women 3Health News:Caring Counseling May Ease Postpartum Depression 2Health News:Caring Counseling May Ease Postpartum Depression 3Health News:National Prayer Vigil for Life Opening Mass 2Health News:Lupin is Granted USFDA Approval for Levetiracetam Tablets 2Health News:Teleconference on Monday, January 19, Announcing New, Innovative Dual Iron Supplement Now Available Over the Counter 2Health News:Includesdental.com Announces Search Engine for Dentists, Hygienists and Oral Health Industry 2